Related Experiment Video
Updated: Jul 11, 2025
10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
8.1K
Palliative Care in Children with Inherited Metabolic Diseases: Why does it matter?
Joana Pereira Mendes1, Andreia Nogueira1, Ema Grilo1
1Paediatric Palliative Care Team, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Portugal.
Endocrine, Metabolic & Immune Disorders Drug Targets
|November 3, 2023
Summary
Paediatric palliative care teams (PPCT) support children with inherited metabolic diseases (IMD) at home and in end-of-life planning. Referral to PPCTs reduced emergency department admissions, offering crucial emotional and bereavement support to families.
Area of Science:
- Pediatric Palliative Care
- Inherited Metabolic Diseases
- Healthcare Resource Utilization
Background:
- Inherited metabolic diseases (IMD) impose significant burdens on children and families, with challenges in symptom identification, prognostic uncertainty, and bereavement.
- Literature on the impact of paediatric palliative care (PPC) for these complex cases is limited.
Purpose of the Study:
- To evaluate children with IMD referred to a PPC team (PPCT).
- To analyze the impact of PPCT on home care, treatment limitations, hospital resource use, and end-of-life support.
Main Methods:
- Retrospective cohort study of children with IMD referred to a specialized PPCT from 2016-2022.
- Assessed clinical data including symptom control, referral timing, follow-up duration, treatment limitations, device dependency, hospital resource use (prior to and after referral), place of death, and end-of-life support.
Main Results:
- Fifteen children with IMD (median age 7 years) were referred to PPCT; 73% received home PPC and 80% had planned limitations on treatment.
- A decrease in emergency department admissions was observed post-referral (10 vs 2), though hospital and intensive care admissions remained similar.
- Six children died during the study period, all with planned treatment limitations, and 67% received PPCT support at end-of-life, with families receiving emotional and bereavement support.
Conclusions:
- Children with severe, complex IMD require extensive medical support and consume significant healthcare resources.
- Communication impairments in non-verbal children pose challenges for symptom assessment.
- PPCT referral facilitated home support, advance care planning, and reduced emergency visits, highlighting the need for a holistic approach to PPC for children with IMD.
Keywords:
ChildrenComplexityHome careHospital resourcesInherited metabolic diseasesPaediatric palliative care referralMore Related Videos
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
12.0K
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
Published on: November 23, 2011
36.8K
Related Concept Videos
01:20Inborn Errors of Metabolism
166
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
166
01:25Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:21Overview of Protein Metabolism
1.2K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.2K
01:29Chronic Pancreatitis II: Collaborative Care
95
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
95